Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Expert Review of Clinical Immunology|October 31, 2019
Biologic discontinuation strategies and outcomes in patients with rheumatoid arthritisGiulio Cavalli, Ennio Giulio FavalliDrug Development Research|November 11, 2014
Ten-year drug survival of anti-TNF agents in the treatment of inflammatory arthritidesMartina Biggioggero, Ennio Giulio FavalliBiomed Research International|February 9, 2019
The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha InhibitorsMartina Biggioggero, Federica Mesina, Ennio Giulio FavalliRMD Open|November 12, 2015
Structural integrity versus radiographic progression in rheumatoid arthritisEnnio Giulio Favalli, Andrea Becciolini, Martina BiggioggeroClinical and Experimental Rheumatology|January 22, 2018
Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis: a cost-consequence analysis in the Italian settingSergio Iannazzo, Maurizio Benucci, Ennio Giulio FavalliThe Journal of International Medical Research|September 30, 2016
The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registryAndrea Becciolini, Martina Biggioggero, Ennio Giulio FavalliExpert Opinion on Drug Discovery|June 27, 2022
Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritisGabriella Maioli, Roberto Caporali, Ennio Giulio FavalliDrugs|July 1, 2024
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic DrugsEnnio Giulio Favalli, Gabriella Maioli, Roberto CaporaliAutoimmunity Reviews|February 8, 2011
Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literatureFrancesca Ingegnoli, Ennio Giulio Favalli, Pier Luigi MeroniAutoimmunity Reviews|November 17, 2019
The Giants (biologicals) against the Pigmies (small molecules), pros and cons of two different approaches to the disease modifying treatment in rheumatoid arthritisEnnio Giulio Favalli, Marco Matucci-Cerinic, Zoltan SzekaneczPageof 10